NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Viral Therapy


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
New chemistry research from M. Sala et al outlined
2009 NOV 27 ... Republic, City:Prague, Country:Czech Republic, Life Sciences, Virology, Coxsackie Virus, Viral Research, Therapy, Treatment, Nucleoside Analog, Organic Chemistry.This ...
Subject: Chemistry
Price: $3.00
*
No-entry zones for AIDS virus
2009 NOV 29 ... block the work of an enzyme called integrase, which is responsible for integrating the viral DNA into the DNA of the infected cell.This enzyme is currently in the focus ... trying to find out whether AIDS viruses can be used as gene delivery vehicles in gene therapy. Therefore, it is crucial for them to know where exactly HIV integrates into the genetic ...
Subject: Helmholtz Association of German Research Centres
Price: $3.00
*
Research from R.A. Giron and co-researchers in the area of cervical cancer published
2009 NOV 23 ... Enzymes, Human Papilloma Virus, Oncology, Papilloma, Therapy, Transferase, Treatment, Viral Research, Virology, Women's Health. This article was prepared by Biotech ...
Subject: Cervical Cancer
Price: $3.00
*
Research from University of Sydney has provided new information about hepatitis C virus
2009 NOV 23 ... combined P = 9.25 x 10(-9), OR = 1.98, 95% CI = 1.57-2.52). IL28B contributes to viral resistance and is known to be upregulated by interferons and by RNA virus infection," ... study of sustained virological response (SVR) to PEG-IFN-alpha/RBV combination therapy in 293 Australian individuals with genotype 1 chronic hepatitis C, with validation in an ...
Subject: Hepatitis C Virus
Price: $3.00
*
Research on hepatitis C virus detailed by scientists at Rockefeller University, Center for the Study of Hepatitis C
2009 NOV 23 ... Disease, Interferon, Pre-Trials Research, Treatment, Vaccines, Viral Inhibition, Viral Therapy, Virology. This article was prepared by Biotech Business Week editors from ...
Subject: Hepatitis C Virus
Price: $3.00
*
Research on multiple sclerosis published by scientists at Technical University of Munich
2009 NOV 23 ... Multiple Sclerosis, Neuroimmunology, Neurology, Polymerase, Treatment, Viral Inhibition, Viral Therapy, Virology, Technical University of Munich. This article was prepared by ...
Subject: Multiple Sclerosis
Price: $3.00
*
Research reports on HIV/AIDS from H.L. Okunola and colleagues provide new insights
2009 NOV 23 ... Alfa-2b, Intron, Pharmaceuticals, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology. This article was prepared by AIDS Weekly editors from staff and ...
Subject: HIV/AIDS
Price: $3.00
*
Researchers mobilizing global resources to test new treatments for severe H1N1 infection
2009 NOV 23 ... spend two weeks in the ICU. Right now H1N1 infection is treated with anti-viral drugs and other supportive measures. But researchers want to evaluate two classes of ... Diseases, Marketing and Licensing Agreements, Pandemics, Swine Flu, Swine Influenza, Therapy, Treatment, St. Michael's Hospital. This article was prepared by Biotech ...
Subject: St. Michael's Hospital
View Free
Daily News
Article
Researchers' work from Children's Hospital focuses on life sciences
2009 NOV 23 ... MNP represents a promising approach with a potential to extend the applicability of the viral gene therapeutic strategies." Chorny and colleagues published their study ... Life Sciences, Pediatrics, Virology, Molecular Pharmacology, Molecular Therapies, Therapy, Treatment, Biotechnology, Gene Therapy, Genetics, Genomics, Pharmaceuticals, ...
Subject: Life Sciences
Price: $3.00
*
Scientists at University of Liverpool detail research in HIV/AIDS therapy
2009 NOV 23 ... are powered to detect a difference between treatment arms of 10-12% for the endpoint of viral load suppression <50 HIV-1 RNA copies/mL." "The TITAN trial evaluated ... St., Malden, MA 02148, USA. Keywords: United Kingdom, Liverpool, HIV/AIDS Therapy, AIDS, Acquired Immunodeficiency Syndrome, Clinical Trial Research, Darunavir, Drugs, ...
Subject: HIV/AIDS Therapy
Price: $3.00
*
Scientists successfully reprogram blood cells
2009 NOV 28 ... syndrome that were cultured in the laboratory. They successfully used what is called a viral vector (in this case a lentivirus) to insert a healthy version of the IDUA gene into ... Academy of Sciences.The study suggests a new approach to molecular gene therapy and a much-needed improved treatment option for children with Hurler's syndrome, said ...
Subject: Cincinnati Children's Hospital Medical Center
Price: $3.00
*
Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
2009 NOV 23 ... reprogramming technologies offered under the terms of the agreement involve proprietary viral vectors from Stemgent, lentivirus technology from Sigma-Aldrich and Dox Inducible ... Biomedicine, Biotechnology, Biotechnology Business, Biotechnology Company, Gene Therapy, Genetics, Genomics, Marketing and Licensing Agreements, Regenerative Medicine, Stem ...
Subject: Regenerative Medicine
Price: $3.00
*
Studies from A. Talwar et al add new findings in the area of virology
2009 NOV 23 ... Hypertension, Immunology, Pulmonology, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology. This article was prepared by Anti-Infectives Week editors from ...
Subject: Virology
Price: $3.00
*
Studies in the area of hepatitis C virus reported from P. Hauser and co-researchers
2009 NOV 23 ... Disorder, Mental Health, Psychiatric, Psychiatry, Treatment, Viral Inhibition, Viral Therapy, ViroLogic Inc., Virology. This article was prepared by Biotech Business ...
Subject: Hepatitis C Virus
Price: $3.00
*
Studies in the area of virology reported from J.H. Huang and co-researchers
2009 NOV 23 ... ischemic limb or heart. In this study, we constructed a human Ang-1-expressing Sendai viral vector (SeVhAng-1) and injected it into the ischemic limb of rats," scientists in ... "Sendai virus vector is emerging as a promising vector for gene therapy, and angiopoietin-1 (Ang-1) has been reported to improve the blood flow recovery in the ...
Subject: Virology
Price: $3.00
*
Study findings on virology are outlined in reports from D. Bacardi and colleagues
2009 NOV 23 ... Infectious Disease, Medical Device, Pancreas, Therapy, Treatment, Vaccination, Viral, Virology. This article was prepared by Biotech Business Week editors from ...
Subject: Virology
Price: $3.00
*
Study results from University of Zurich in the area of HIV/AIDS therapy published
2009 NOV 23 ... Inhibitor, Pharmaceuticals, Proteins, Proteomics, Therapy, Treatment, Viral Inhibition, Viral Therapy, Virology. This article was prepared by AIDS Weekly editors from staff and ...
Subject: HIV/AIDS Therapy
Price: $3.00
*
U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain
2009 NOV 23 ... Virus, Herpesvirus, Neurology, Neuropathic Pain, Pharmaceuticals, Therapy, Treatment, Viral, Virology, University of Michigan Health System. This article was prepared ...
Subject: Herpes Simplex
Price: $3.00
*
University of Alabama details research in herpes simplex
2009 NOV 23 ... Neuro-Oncology, Oncology, Progenitor Cells, Stem Cell Research, Therapy, Treatment, Viral, Virology, Xenograft, Xenotransplantion, University of Alabama. This ...
Subject: Herpes Simplex
Price: $3.00
*
Viron to Present Data from Phase II Trial at American Heart Association Conference
2009 NOV 23 ... Viron Therapeutics Inc., a biopharmaceutical company pioneering the development of viral protein therapeutics, announced that the Company's research collaborator, Dr. ... Genetics, Biopharmaceuticals, Drugs, Pharmaceuticals, Clinical Trial Research, Therapy, Treatment This article was prepared by Biotech Business Week editors from ...
Subject: Viron Therapeutics Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login